NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-106-1993-0-JP-10 IMMUNOGENIC CHIMERAS COMPRISING NUCLEIC ACID SEQUENCES ENCODING ENDOPLASMIC RETICULUM SIGNAL SEQUENCE PEPTIDES AND AT LEAST ONE OTHER PEPTIDE, AND THEIR USES IN VACCINES AND DISEASE TREATMENTS JP DIV 2005-197523 Abandoned
NIDDK E-133-2005-0-US-01 Genomic Nucleic Acid Sequence for Cyanovirin-N and Signal Peptide Thereof US 60/696,599 Abandoned
NIAID E-031-2004-3-US-01 Anti-Tubercular Drug: Compositions And Methods US CIP 11/173,192 7456222 Expired PDF
NCI E-210-2005-0-US-01 The Mitotic Spindle Protein ASPM As A Diagnostic Marker For Malignancy US 60/696,212 Abandoned
NINDS E-251-2005-0-US-01 Method for enhance recovery Of motor control via Vibro-tactile Stimulation To an affected system US 60/695,424 Abandoned
NCI E-216-2005-0-US-01 Germline Polymorphism Of SIPA1 Are Associated With Nodal And Distant Metastases In Breast Cancer US 60/695,024 Abandoned
NIAID E-259-2005-0-US-01 PURIFIED TRlMERlC S PROTEIN AS VACCINE AGAINST SEVERE ACUTE RESPIRATORY SYNDROME VIRUS INFECTIONS US 60/694,460 Abandoned
NIDDK E-141-2003-0-US-03 Monoclonal Antibodies to HIV-1 and Methods of Using Same US ORD 11/630,880 7993647 Issued PDF
NICHD E-309-2000-0-US-03 Probe Using Diffuse-Reflectance Spectroscopy US CON 11/168,286 7302287 Abandoned PDF
NIA E-092-2004-0-US-01 Anti-Marinobufagenin Antibody (Clone 3EG) And Uses To Treat Hypertension, Pre-eclampsia, And Eclampsia US 60/694,733 Abandoned
NIBIB E-223-2005-0-US-01 A Spatially Selective, Fixed Optics Multicolor Flourescence Detection System For A Multichannel Plastic Microfluidic Device US 60/693,780 Abandoned
NIDDK E-185-1999-0-US-04 Multispectral/Hyperspectral Medical Instrument US DIV 11/165,587 8175688 Expired PDF
NIAMS E-061-1997-0-US-02 PHAGE DISPLAY OF INTACT DOMAINS AT HIGH COPY NUMBER US DIV 11/166,457 Abandoned
NIAID E-095-2000-2-US-01 AMELIORATION OF INFLAMMATORY ARTHRITIS BY TARGETING THE PRE-LIGAND ASEEMBLY DOMAIN (PLAD) OF TUMOR NECROSIS FACTOR RECEPTORS US 60/694,015 Abandoned
NCI E-072-2004-2-US-02 An HIV Protein As A Novel Target For Therapy And Vaccination US CON 11/165,444 Abandoned
NIAID E-217-2004-0-CA-03 Safer Attenuated Virus Vaccines with Missing or Diminished Latency of Infection CA National Stage 2571261 Issued
NIDDK E-141-2003-0-EP-04 MONOCLONAL ANTIBODIES TO HIV-1 VPR AND METHODS OF USING SAME EP National Stage 05766543.2 Issued
NIAID E-217-2004-0-IN-04 Safer Attenuated Virus Vaccines with Missing or Diminished Latency of Infection IN National Stage 7861/DELNP/2006 Issued
NIAID E-217-2004-0-PCT-02 Safer Attenuated Virus Vaccines with Missing or Diminished Latency of Infection PCT PCT PCT/US2005/21788 Expired
NIDDK E-141-2003-0-PCT-02 Monoclonal Antibody-based Methodologies For The Detection And Quantification Of The HIV-1 Accessory Protein Vpr In Biological SamplesP PCT PCT PCT/US2005/022135 Expired
NIEHS E-265-2006-0-JP-01 Accelerating agent of neurogenesis JP ORD 2005-181699 Abandoned
CC E-093-2005-0-US-02 DEVICE AND METHOD FOR TRACKABLE ULTRASOUND US ORD 11/471,629 9398892 Issued PDF
CC E-093-2005-0-US-01 Laparascopic Ultrasound Transducer Trackable With Magnetics US 60/692,271 Abandoned
NCI E-104-2005-1-US-01 Furin Inhibitors For Prevention Of Papillomarvirus Infection US 60/692,846 Abandoned
NCI E-302-2000-2-US-04 Inhibition of Mitogen-Activated Protein Kinase (MAPK) Pathway: A Selective Therapeutic Strategy Against Melanomas US DIV 11/155,691 7612035 Expired PDF
NINDS E-306-2003-1-US-01 DIFFERENTIAL EXPRESSION OF MOLECULES ASSOCIATED WITH ACUTE STROKE US CIP 11/155,835 7749700 Abandoned PDF
NCI E-281-2003-2-US-01 Cathepsin G-Related Peptides as Modulators of Formylpeptide Receptors (FPR US ORD 11/154,744 Abandoned
NCI E-085-2003-2-MX-05 Cyanovirin Variant-Polymer Conjugates MX National Stage 2005/006688 Expired
NINDS E-030-2005-1-US-01 Differential Expression of Molecules Associated with Vascular Disease Risk US 60/691,730 Abandoned
NINDS E-301-2007-0-US-01 Transcranial Magnetic Stimulation System and Methods US ORD 11/153,905 7976451 Issued PDF
NIDDK E-102-2004-0-PCT-02 An Improved Method For The Generation Of Polycolonal Antibodies To Treat Leukocyte Mediated Counter-adapted Immunity PCT PCT PCT/US2005/21364 Expired
NIEHS E-069-2007-2-PCT-01 The Cysteine-rich Region Of Respiratory Syncytial Virus And Methods Of Use Thereof PCT PCT COMB PCT/US2005/021538 Expired
NCI E-243-2002-1-JP-05 Recombinant Vaccine Viruses Expressing IL-15 and Methods of Using Same JP National Stage 2004-563586 Abandoned
NHGRI E-149-2005-0-PCT-01 Methods and Materials for Identifying Polymorphic Variants, Diagnosing Susceptibilities, and Treating Disease PCT PCT PCT/US2005/021288 Expired
NIDDK E-102-2004-0-EP-05 ANTI-LYMPHO- PLUS ANTI-MONOCYTES GLOBULIN PREPARATION FOR INHIBITING IMMUNE RESPONSES EP National Stage 05817336.0 Abandoned
NIEHS E-069-2007-2-EP-03 THE CYSTEINE-RICH REGION OF RESPIRATORY SYNCYTIAL VIRUS AND METHODS OF USE THEREFOR EP National Stage 05810236.9 Abandoned
NCI E-075-2004-2-EP-04 Methods for the Identification and Use of Compounds Suitable for the Treatment of Drug Resistant Cancer Cells EP National Stage 05766603.4 Abandoned
NCI E-075-2004-2-AU-02 Methods for the Identification and Use of Compounds Suitable for the Treatment of Drug Resistant Cancer Cells AU National Stage 2005265027 Abandoned
NIDDK E-102-2004-0-AU-03 ANTI-LYMPHO- PLUS ANTI-MONOCYTES GLOBULIN PREPARATION FOR INHIBITING IMMUNE RESPONSES AU National Stage 2005287392 Abandoned
NCI E-075-2004-2-PCT-01 Methods for the Identification and Use of Compounds Suitable for the Treatment of Drug Resistant Cancer Cells PCT PCT COMB PCT/US05/021253 Expired
NIDDK E-102-2004-0-CA-04 Anti-Lympho- Plus Anti-Monocytes Globulin Preparation for Inhibiting Immune Responses CA National Stage 2571272 Abandoned
NCI E-075-2004-2-CA-03 Methods for the Identification and Use of Compounds Suitable for the Treatment of Drug Resistant Cancer Cells CA National Stage 2570501 Abandoned
NIAMS E-116-2005-0-US-01 Cell-nanofiber Composite Based Engineered Cartilage US 60/690,988 Abandoned
NIDCR E-035-2010-1-US-01 INTEGRIN CD18 IS A NOVEL STROMAL STEM CELL MARKER AND FUNCTIONS TO PROMOTE OSTEOGENESIS US 60/690,767 Abandoned
NIDDK E-063-2005-0-US-01 Process For The Synthesis Of Anticonvulsive Agents Of 2-carboxyquinoline Derivatives3 US 60/689,809 Abandoned
NIDA E-089-2005-0-US-01 BENZTROPINAMINE ANALOGS US 60/689,746 Abandoned
NCI E-139-2005-0-US-01 Identification Of A Novel Binding Protein Binding Protein, FBP-1 US 60/689,749 Abandoned
NIDDK E-104-1989-0-US-15 BIOLOGICALLY ACTIVE SYNTHETIC THYROTROPIN AND CLONED GENE FOR PRODUCING SAME US CON 11/148,604 Abandoned
NCI E-233-2004-1-US-01 Live Microbial Microbicides US 60/688,376 Abandoned
NCI E-207-2005-0-US-01 ANALYSIS OF LARGE NUMBERS OF ESTROGENS AND OTHER STEROIDS AND
APPLICATIONS THEREOF 		US 60/688,160 Abandoned